EE200200605A - Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks - Google Patents

Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks

Info

Publication number
EE200200605A
EE200200605A EEP200200605A EEP200200605A EE200200605A EE 200200605 A EE200200605 A EE 200200605A EE P200200605 A EEP200200605 A EE P200200605A EE P200200605 A EEP200200605 A EE P200200605A EE 200200605 A EE200200605 A EE 200200605A
Authority
EE
Estonia
Prior art keywords
glutathione
medicament
substituted
manufacture
treatment
Prior art date
Application number
EEP200200605A
Other languages
English (en)
Estonian (et)
Inventor
Cristina Rosa Geroni Maria
Cozzi Paolo
Beria Italo
Original Assignee
Pharmacia Italia S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia S.P.A. filed Critical Pharmacia Italia S.P.A.
Publication of EE200200605A publication Critical patent/EE200200605A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
EEP200200605A 2000-05-08 2001-04-19 Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks EE200200605A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0011059.3A GB0011059D0 (en) 2000-05-08 2000-05-08 Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
PCT/EP2001/004470 WO2001085144A2 (en) 2000-05-08 2001-04-19 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione

Publications (1)

Publication Number Publication Date
EE200200605A true EE200200605A (et) 2004-04-15

Family

ID=9891173

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200605A EE200200605A (et) 2000-05-08 2001-04-19 Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks

Country Status (29)

Country Link
US (1) US7030089B2 (de)
EP (1) EP1280527B1 (de)
JP (1) JP2003532669A (de)
KR (1) KR100776184B1 (de)
CN (1) CN1258362C (de)
AR (1) AR029518A1 (de)
AT (1) ATE300944T1 (de)
AU (2) AU2001260227B2 (de)
BR (1) BR0110628A (de)
CA (1) CA2409664C (de)
CZ (1) CZ300791B6 (de)
DE (1) DE60112423T2 (de)
DK (1) DK1280527T3 (de)
EA (1) EA007506B1 (de)
EE (1) EE200200605A (de)
ES (1) ES2244618T3 (de)
GB (1) GB0011059D0 (de)
HK (1) HK1054193B (de)
HU (1) HUP0301882A2 (de)
IL (2) IL152388A0 (de)
MX (1) MXPA02010962A (de)
NO (1) NO20025303L (de)
NZ (1) NZ522234A (de)
PL (1) PL201289B1 (de)
PT (1) PT1280527E (de)
SK (1) SK286501B6 (de)
TW (1) TWI284643B (de)
WO (1) WO2001085144A2 (de)
ZA (1) ZA200208531B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015446D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0016447D0 (en) 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
IT1318696B1 (it) * 2000-09-15 2003-08-27 Pharmacia & Upjohn Spa Coniugati di glutatione con derivati della distamicina ad attivita'antitumorale.
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
ES2299692T3 (es) * 2002-04-02 2008-06-01 Nerviano Medical Sciences S.R.L. Terapia combinada contra tumores que comprende derivados de distmicina acriloil sustituido y radioterapia.
ES2867965T3 (es) * 2015-10-15 2021-10-21 Advanced Biodesign Compuestos de aminotioléster o sales farmacéuticamente aceptables de los mismos, para utilizar en el tratamiento del cáncer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387013B (de) 1985-07-16 1988-11-25 Erba Farmitalia Verfahren zur herstellung von poly-4-aminopyrrol -2-carboxamidoderivaten
GB8612218D0 (en) 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents
DE3768419D1 (de) 1986-10-07 1991-04-11 Boehringer Biochemia Srl Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
GB8906709D0 (en) * 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
JP2919867B2 (ja) 1989-09-27 1999-07-19 千寿製薬株式会社 抗腫瘍剤
IT1272234B (it) * 1994-05-02 1997-06-16 Consiglio Nazionale Ricerche Derivati glutationici delle antracicline e procedimento per ottenerli.
GB9416005D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5880097A (en) * 1996-01-04 1999-03-09 Terrapin Techologies, Inc. Tethered prodrugs
CA2244139C (en) 1996-02-02 2005-06-07 Pharmacia & Upjohn S.P.A. Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9610079D0 (en) 1996-05-14 1996-07-17 Pharmacia Spa Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
GB9806692D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB9806689D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
GB9816653D0 (en) 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Oxidised sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9816652D0 (en) 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9928703D0 (en) * 1999-12-03 2000-02-02 Pharmacia & Upjohn Spa Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione

Also Published As

Publication number Publication date
IL152388A0 (en) 2003-05-29
SK16002002A3 (sk) 2003-04-01
ZA200208531B (en) 2003-10-22
NO20025303D0 (no) 2002-11-05
DK1280527T3 (da) 2005-10-17
WO2001085144A2 (en) 2001-11-15
NO20025303L (no) 2002-11-05
HK1054193A1 (en) 2003-11-21
EA200201184A1 (ru) 2003-04-24
CN1427719A (zh) 2003-07-02
CZ20023629A3 (cs) 2003-03-12
EA007506B1 (ru) 2006-10-27
CZ300791B6 (cs) 2009-08-12
KR20030019371A (ko) 2003-03-06
AU6022701A (en) 2001-11-20
EP1280527A2 (de) 2003-02-05
KR100776184B1 (ko) 2007-11-16
US7030089B2 (en) 2006-04-18
HUP0301882A2 (hu) 2003-09-29
PT1280527E (pt) 2005-10-31
DE60112423D1 (de) 2005-09-08
US20030207794A1 (en) 2003-11-06
CN1258362C (zh) 2006-06-07
IL152388A (en) 2008-04-13
JP2003532669A (ja) 2003-11-05
ATE300944T1 (de) 2005-08-15
NZ522234A (en) 2004-09-24
BR0110628A (pt) 2003-03-18
SK286501B6 (sk) 2008-11-06
WO2001085144A3 (en) 2002-05-16
CA2409664A1 (en) 2001-11-15
HK1054193B (zh) 2007-02-02
EP1280527B1 (de) 2005-08-03
AU2001260227B2 (en) 2005-10-27
AR029518A1 (es) 2003-07-02
GB0011059D0 (en) 2000-06-28
TWI284643B (en) 2007-08-01
PL365831A1 (en) 2005-01-10
DE60112423T2 (de) 2006-05-24
MXPA02010962A (es) 2003-03-27
CA2409664C (en) 2010-01-12
ES2244618T3 (es) 2005-12-16
PL201289B1 (pl) 2009-03-31

Similar Documents

Publication Publication Date Title
AR028238A1 (es) Tratamiento para el tabaco
IL155093A0 (en) Morpholin-acetamide derivatives for the treatment on inflammatory diseases
NO20032909D0 (no) Glukopyranosyloksypyrazolderivater samt medikamentell anvendelse derav
BR0014930B1 (pt) cÂnula.
ATE251625T1 (de) 8-phenyl-6,9-dihydro-(1,2,4)triazolo(3,4-i)puri - 5-on derivate
EE05481B1 (et) Kinasoliini derivaadid kasvajate raviks
BR0016218B1 (pt) artigo para fumar.
DK1596870T4 (da) Højdosis-ibandronatformulering
EE200200605A (et) Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks
AR028321A1 (es) Medicamentos intracorporeos para el tratamiento fototerapeutico de alta energia de enfermedades
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
IT1316950B1 (it) Dispositivo autoumidificante per tracheostomia.
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
MXPA03003032A (es) Terapia de combinacion para el tratamiento de una enfermedad sensible a los estrogenos.
ES1044983Y (es) Aparato de termoestimulacion para tratamientos terapeuticos.
ITMI20001848A0 (it) Faramaci per l'incontinenza.
ITTO20011197A0 (it) Corpo cilindrico ornamentale.
EE200100082A (et) Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks laiaspektrilise ravimresistentsusega P-glükoproteiini ekspresseerivates rakuliinides
ES1051471Y (es) Sandalia multiforme perfeccionada
ES1043995Y (es) Dispositivo para apagar cigarrillos, puros o similares.
ITGE20010007U4 (it) Apparato per trattamenti fisiologici.
ES1043699Y (es) Dispositivo nebulizador.
IT1319368B1 (it) Gioco del bingo perfezionato
LV12535A (lv) Treatment having antioxidant effect for stregthening capillars
ITBN20000004U1 (it) Arazzo-contenitore multiforme.

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner